| __timestamp | Merck & Co., Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7180000000 | 15635076 |
| Thursday, January 1, 2015 | 6704000000 | 23943601 |
| Friday, January 1, 2016 | 7194000000 | 23689111 |
| Sunday, January 1, 2017 | 9982000000 | 41006114 |
| Monday, January 1, 2018 | 9752000000 | 51379106 |
| Tuesday, January 1, 2019 | 9872000000 | 32705593 |
| Wednesday, January 1, 2020 | 13397000000 | 53274000 |
| Friday, January 1, 2021 | 12245000000 | 85352000 |
| Saturday, January 1, 2022 | 13548000000 | 51999000 |
| Sunday, January 1, 2023 | 30531000000 | 59471000 |
Unlocking the unknown
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Merck & Co., Inc. and Summit Therapeutics Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Merck's R&D expenses surged by over 300%, peaking at an impressive $30.5 billion in 2023. This reflects Merck's robust strategy to maintain its competitive edge in the global market. In contrast, Summit Therapeutics, a smaller player, has shown a more modest increase in R&D spending, with a peak of approximately $85 million in 2021. Despite the disparity in absolute numbers, Summit's consistent investment underscores its dedication to innovation within its niche. This comparison highlights the diverse strategies companies employ to drive growth and innovation in the pharmaceutical industry.
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
Analyzing R&D Budgets: Merck & Co., Inc. vs Apellis Pharmaceuticals, Inc.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Dynavax Technologies Corporation
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.